Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134025) titled 'Study on multi-modal data fusion for histopathological grading of bladder cancer' on Oct. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Yuebei People's Hospital
Condition:
Bladder cancer
Intervention:
High grade group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-15
Target Sample Size: High grade group:330;Low grade group:170;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=343571
Disclaimer: Curated by HT Syndication....